Reproterol

Reproterol
Systematic (IUPAC) name
	(RS)-7-(3-{[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]amino}propyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
Clinical data
Drugs.com	International Drug Names
Routes of; administration	Inhalation (MDI), IV
Legal status
Legal status	℞-only (DE);
Identifiers
CAS Number	54063-54-6
ATC code	R03AC15 (WHO)
PubChem	CID 25654
ChemSpider	23898
UNII	11941YC6RN
KEGG	D08474
ChEMBL	CHEMBL1095607
Chemical data
Formula	C18H23N5O5
Molar mass	389.406 g/mol
	SMILES CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCCNCC(C3=CC(=CC(=C3)O)O)O ;
	InChI InChI=1S/C18H23N5O5/c1-21-16-15(17(27)22(2)18(21)28)23(10-20-16)5-3-4-19-9-14(26)11-6-12(24)8-13(25)7-11/h6-8,10,14,19,24-26H,3-5,9H2,1-2H3 ; Key:WVLAAKXASPCBGT-UHFFFAOYSA-N ;
(what is this?) (verify)

Reproterol (INN) is a short-acting^[1] β₂ adrenoreceptor agonist used in the treatment of asthma.^[2]

References[edit]

^ Küpper, T; Goebbels, K; Kennes, LN; Netzer, NC (December 2012). "Cromoglycate, reproterol, or both—what's best for exercise-induced asthma?". Sleep & breathing = Schlaf & Atmung 16 (4): 1229–35. PMID 22198635.
^ Virchow JC Jr. Reproterol: beta-2-agonist, theophylline, or both? Respiration. 1999;66(3):210-1. PMID 10364735

This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.